Western Australia Atropine for the Treatment of Myopia (WA-ATOM) study: Rationale, methodology and participant baseline characteristics.

Home Research Research Publication Western Australia Atropine for the Treatment of Myopia (WA-ATOM) study: Rationale, methodology and participant baseline characteristics.

Lee SSY, Mackey DA, Lingham G, Crewe JM, Richards MD, Chen FK, Charng J, Ng F, Flitcroft I, Loughman JJ, Azuara-Blanco A, Logan NS, Hammond CJ, Chia A, Truong TT, Clark A.

Clin Exp Ophthalmol. 2020 Feb 26. doi: 10.1111/ceo.13736. [Epub ahead of print]

PMID: 32100917

Need any help?

If you would like to know more about us, or want to make an appointment, please don’t hesitate to get in touch.

(08) 9381 0777

carecentre@lei.org.au

Western Australia Atropine for the Treatment of Myopia (WA-ATOM) study: Rationale, methodology and participant baseline characteristics.

Need any help?

Request an appointment